
William A. Haseltine
I am a scientist, businessman, author, and philanthropist. For nearly two decades, I was a professor at Harvard Medical School and Harvard School of Public Health where I founded two academic research departments, the Division of Biochemical Pharmacology and the Division of Human Retrovirology. I am perhaps most well known for my work on cancer, HIV/AIDS, and genomics. My work now also includes efforts to improve access to high quality, affordable healthcare for people in low, middle, and high income countries alike. I am chair and president of ACCESS Health International, a nonprofit organization I founded that fosters innovative solutions to the greatest health challenges of our day. Each of my articles at Forbes.com will focus on a specific healthcare challenge and offer best practices and innovative solutions to overcome those challenges for the benefit of all.
-
新型コロナのパンデミックは終わっていない、過去は恐らく「序章」
-
コロナ変異株の感染拡大、子供と学校の対策強化が急務
-
通学前に自分で抗原検査、オーストリア方式は学校再開のモデルになるか
-
イスラエルの新型コロナワクチン接種の初期データが示すこと
-
新型コロナ変異種にもファイザー製ワクチンは効くのか?
-
米若者の間でがんの診断数が増加 40年ほどで30%アップ
-
新型コロナ感染拡大、ワクチン承認だけでは楽観的になれない理由
-
妊婦は、コロナ感染で重症化しやすく死亡リスクも高い
-
コロナ感染抑制のカギ握るのは14歳以下の子供? 米・伊で報告
-
新型コロナの本当の感染率と有効な対策について、みえてきたこと
-
人間と動物の間の新型コロナ感染 危険性はどれほど?
-
スウェーデンの新型コロナ対策から得るべき教訓とは